Company Filing History:
Years Active: 2017-2019
Title: The Innovative Contributions of Emigdio Reyes in Cancer Diagnostics
Introduction
Emigdio Reyes is a notable inventor based in Philadelphia, PA, recognized for his significant contributions to cancer diagnostics through innovative technologies. With a total of two patents to his name, Reyes has developed groundbreaking methods for detecting circulating tumor cells (CTCs), a crucial element in the early diagnosis and monitoring of cancer.
Latest Patents
Reyes's latest patents focus on compositions, methods, and a microfluidics device for telomerase-based in vitro diagnostic assays for detecting circulating tumor cells. The patented method involves utilizing a non-lytic adenoviral system to detect CTCs from patient test samples. This system includes a replication-defective adenoviral particle containing an expression cassette and a tumor-specific promoter, allowing for the expression of a reporter protein in the presence of CTCs. This innovative approach not only enables the identification of circulating tumor cells but also allows for the repeated testing as the cells remain viable in culture. Additionally, the patent provides a method for enriching test samples containing CTCs and includes a microfluidics device tailored for specific identification and enumeration of these cells.
Career Highlights
Emigdio Reyes is affiliated with the University of Pennsylvania, where he contributes to advancing medical diagnostics through his research and inventions. His expertise in utilizing adenoviral systems has positioned him as a leader in the field of cancer research.
Collaborations
Reyes has worked alongside distinguished colleagues, including Stephen M. Hahn and Jay F. Dorsey. Together, they have collaborated on innovative projects that enhance the understanding and detection of cancer cells, contributing to the scientific community's collective effort in improving cancer diagnostics.
Conclusion
Emigdio Reyes's innovative work in developing methods for detecting circulating tumor cells is a tremendous asset to the field of cancer diagnostics. His patents not only demonstrate his creativity and technical expertise but also have the potential to impact the lives of many patients through improved detection methods. With continued collaboration and research, Reyes's contributions pave the way for advancements in the early diagnosis and treatment of cancer.